Novavax, Inc . NVAX was a big mover last session, as the company saw its shares rise over 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $1.88 -$2.23 in the past one-month time frame, witnessed a sharp increase yesterday.
The company has seen no estimate revisions in the past two months, while its Zacks Consensus Estimate for the current quarter has also remained unchanged over the same time frame. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Novavax currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Novavax, Inc. Price and Consensus
A better-ranked stock in the Medical - Biomedical and Genetics industry is Regeneron Pharmaceuticals, Inc. REGN , which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today's Zacks #1 Rank stocks here .
Can Hackers Put Money INTO Your Portfolio?
Earlier this month, credit bureau Equifax announced a massive data breach affecting 2 out of every 3 Americans. The cybersecurity industry is expanding quickly in response to this and similar events. But some stocks are better investments than others.
Zacks has just released Cybersecurity! An Investor's Guide to help Zacks.com readers make the most of the $170 billion per year investment opportunity created by hackers and other threats. It reveals 4 stocks worth looking into right away.